Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
OXL-H82Q6 | Human | Biotinylated Human OX40 Ligand / TNFSF4 Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
OXL-H82F4 | Human | Biotinylated Human OX40 Ligand / TNFSF4 Protein, Avitag™,Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
OXL-H5250 | Human | Human OX40 Ligand / TNFSF4 Protein, Mouse IgG2a Fc Tag, low endotoxin | ![]() |
![]() ![]() |
![]() ![]() |
OXL-R5259 | Rhesus macaque | Rhesus macaque OX40 Ligand / TNFSF4 Protein, Mouse IgG2a Fc Tag, low endotoxin | ![]() |
![]() ![]() |
![]() ![]() |
TN4-M5241 | Mouse | Mouse OX40 Ligand / TNFSF4 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
OXL-M526x | Mouse | Mouse OX40 Ligand / TNFSF4 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
OXL-H526x | Human | Human OX40 Ligand / TNFSF4 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
OXL-H52Q8 | Human | Human OX40 Ligand / TNFSF4 Protein, His Tag (active trimer) (MALS verified) | ![]() |
![]() ![]() ![]() ![]() |
![]() ![]() |
FACS assay shows that recombinant Human OX40 Ligand, Mouse IgG2a Fc Tag, low endotoxin (Cat. No. OXL-H5250) can bind to 293T cell overexpressing human OX40. The concentration of OX40 Ligand is 0.003 μg/ml (Routinely tested).
FACS analysis shows that the binding of Human OX40 Ligand, Mouse IgG2a Fc Tag, low endotoxin (Cat. No. OXL-H5250) to 293T overexpressing OX40 was inhibited by increasing concentration of neutralizing anti-OX40 antibody. The concentration of OX40 Ligand used is 0.002 μg/ml. IC50=3.021 μg/ml (Routinely tested).
Loaded Human OX40 Ligand, Mouse IgG2a Fc Tag, low endotoxin (Cat. No. OXL-H5250) on Protein A Biosensor, can bind Human OX40, His Tag (Cat. No. OX0-H5224) with an affinity constant of 2 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
KY-1005 | KY-1005 | Phase Ⅱ | Kymab | Autoimmune diseases, Atopic dermatitis | Details |
Oxelumab | R-4930; RG-4930; RO-4989991; Roche-4; huMAb-OX40L; OX40L-huMab | Phase Ⅱ | Genentech, Genmab | Allergic asthma | Details |
mRNA-2416 | mRNA-2416; OX40L mRNA - Moderna Therpeutics | Phase Ⅱ | Moderna Therapeutics | Solid tumours, Lymphoma | Details |
This web search service is supported by Google Inc.